BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2161846)

  • 1. Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors.
    Ellis V; Wun TC; Behrendt N; Rønne E; Danø K
    J Biol Chem; 1990 Jun; 265(17):9904-8. PubMed ID: 2161846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.
    Cubellis MV; Andreasen P; Ragno P; Mayer M; Danø K; Blasi F
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4828-32. PubMed ID: 2544876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.
    Nykjaer A; Kjøller L; Cohen RL; Lawrence DA; Garni-Wagner BA; Todd RF; van Zonneveld AJ; Gliemann J; Andreasen PA
    J Biol Chem; 1994 Oct; 269(41):25668-76. PubMed ID: 7929271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the cellular binding site for the urokinase-type plasminogen activator.
    Estreicher A; Wohlwend A; Belin D; Schleuning WD; Vassalli JD
    J Biol Chem; 1989 Jan; 264(2):1180-9. PubMed ID: 2536017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1.
    Cubellis MV; Wun TC; Blasi F
    EMBO J; 1990 Apr; 9(4):1079-85. PubMed ID: 2157592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation.
    Behrendt N; List K; Andreasen PA; Danø K
    Biochem J; 2003 Apr; 371(Pt 2):277-87. PubMed ID: 12534347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor.
    Ballance DJ; Marshall JM; Cottingham IR; Steven J; Berry SJ; Cederholm-Williams SA; Goodey AR; Courtney M
    Eur J Biochem; 1992 Jul; 207(1):177-83. PubMed ID: 1321039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes.
    Estreicher A; Mühlhauser J; Carpentier JL; Orci L; Vassalli JD
    J Cell Biol; 1990 Aug; 111(2):783-92. PubMed ID: 2166055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes.
    Nykjaer A; Petersen CM; Møller B; Jensen PH; Moestrup SK; Holtet TL; Etzerodt M; Thøgersen HC; Munch M; Andreasen PA
    J Biol Chem; 1992 Jul; 267(21):14543-6. PubMed ID: 1378833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ; Lee SW; Dichek DA; Ellis V
    J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation.
    Baker MS; Bleakley P; Woodrow GC; Doe WF
    Cancer Res; 1990 Aug; 50(15):4676-84. PubMed ID: 2114945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor.
    Olson D; Pöllänen J; Høyer-Hansen G; Rønne E; Sakaguchi K; Wun TC; Appella E; Danø K; Blasi F
    J Biol Chem; 1992 May; 267(13):9129-33. PubMed ID: 1315748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).
    Petersen LC
    Eur J Biochem; 1997 Apr; 245(2):316-23. PubMed ID: 9151959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alveolar macrophage urokinase receptors localize enzyme activity to the cell surface.
    Chapman HA; Bertozzi P; Sailor LZ; Nusrat AR
    Am J Physiol; 1990 Dec; 259(6 Pt 1):L432-8. PubMed ID: 2175557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
    Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A
    J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.
    Pöllänen J; Vaheri A; Tapiovaara H; Riley E; Bertram K; Woodrow G; Stephens RW
    Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2230-4. PubMed ID: 2138329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage.
    Wohn KD; Kanse SM; Deutsch V; Schmidt T; Eldor A; Preissner KT
    Thromb Haemost; 1997 Mar; 77(3):540-7. PubMed ID: 9066008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate.
    Picone R; Kajtaniak EL; Nielsen LS; Behrendt N; Mastronicola MR; Cubellis MV; Stoppelli MP; Pedersen S; Danø K; Blasi F
    J Cell Biol; 1989 Feb; 108(2):693-702. PubMed ID: 2537321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
    Schuster WA; Medcalf RL; Kruithof EK
    Endocrinology; 1993 Oct; 133(4):1724-30. PubMed ID: 8404615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of single-chain prourokinase to the urokinase receptor of human U937 cells.
    Cubellis MV; Nolli ML; Cassani G; Blasi F
    J Biol Chem; 1986 Dec; 261(34):15819-22. PubMed ID: 3023326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.